Institutional investors purchased a net $31.8 million shares of PDLI during the quarter ended September 2015 and now own 75.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RUSSELL INVESTMENT MANAGEMENT CO... Bought 1.1 Million shares of PDL BioPharma Inc
CONNOR, CLARK & LUNN INVESTMENT ... Bought 901.1 Thousand shares of PDL BioPharma Inc
AJO LP Bought 519.8 Thousand shares of PDL BioPharma Inc